A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI: Insights from the Zwolle acute myocardial infarction registry

BACKGROUND: Despite the proven benefit of glycoprotein IIb/IIIa blockers in patients with acute ST-segment elevation myocardial infarction (STEMI), there is still debate on the timing of administration of these drugs and whether all or only a selection of patients should be treated. We evaluated the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Heestermans, A.A.C.M., Hermanides, R.S., Gosselink, A.T.M., de Boer, M.J., Hoorntje, J.C.A., Suryapranata, H., Ottervanger, J.P., Dambrink, J-H.E., Kolkman, E., ten Berg, J.M., Zijlstra, F., van ’t Hof, A.W.J.
Formato: Artigo
Idioma:Inglês
Publicado em: Bohn Stafleu van Loghum 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018604/
https://ncbi.nlm.nih.gov/pubmed/21301621
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados